EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Post-transcriptional activation of TGF-β signaling via SMAD mRNA stabilization by EIF4A3 promotes EMT and metastasis in gastric cancer

Yujing Liu, Yanhua Zhang, Wenhuan Dou, Wei Peng, Ming Cheng, Yan Zhou, Qiankun Shao, Yongyou Wu

Cell Biology and Toxicology · 2026

DOI: 10.1007/s10565-026-10171-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2026. Verfasst von Yujing Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Soochow University, Gusu District, No. 1055, Sanxiang Road, Suzhou, 215008,…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epithelial-Mesenchymal Transition, Eukaryotic Initiation Factor-4A, Transforming Growth Factor beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gastric cancer (GC) is characterized by high mortality due to late-stage diagnosis and aggressive metastatic behavior. Epithelial-mesenchymal transition (EMT), primarily driven by the TGF-β/SMAD signaling, critically contributes to GC progression. However, the molecular mechanisms regulating this pathway remain incompletely understood. METHODS: We investigated the expression, function, and regulatory mechanisms of EIF4A3 in GC using patient tissues, GC cell lines, and in vivo mouse models. We performed loss-of-function experiments and xenograft studies to assess the biological effects of EIF4A3. Mechanistic studies were applied for exploring the relation between EIF4A3 and TGF-β/SMAD signaling. RESULTS: EIF4A3 upregulation was observed in GC samples as well as cell lines compared to normal counterparts, and indicated advanced clinical stages and poor clinical outcomes. EIF4A3 knockdown markedly repressed GC cell growth and DNA synthesis in vitro, while restraining tumor growth and Ki67 expression in xenograft models. Silencing EIF4A3 impaired cell migration, invasion, and lung metastasis, and reversed TGF-β induced EMT marker expression. Mechanistically, TGF-β1 transcriptionally induced EIF4A3 via SMAD2/3 binding to its promoter. In turn, EIF4A3 enhanced TGF-β/SMAD signaling by directly binding to and stabilizing SMAD2, SMAD3, and SMAD4 mRNAs, prolonging their half-lives and promoting their phosphorylation and nuclear accumulation. Furthermore, EIF4A3 knockdown reduced SMAD2/3 phosphorylation, nuclear translocation, and downstream EMT marker expression, thereby attenuating the pro-metastatic effects of TGF-β signaling. CONCLUSIONS: Our study identifies EIF4A3 as a critical post-transcriptional regulator and downstream effector of the TGF-β/SMAD pathway. EIF4A3 forms a positive feedback loop with TGF-β/SMAD signaling, thereby reinforcing EMT and promoting metastatic progression in GC. These findings establish EIF4A3 as a novel post-transcriptional amplifier of TGF-β signaling and a promising candidate for diagnostic and therapeutic intervention in metastatic GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsEpithelial-Mesenchymal TransitionEukaryotic Initiation Factor-4ATransforming Growth Factor betaSmad ProteinsHumansAnimalsSignal TransductionCell Line, TumorMiceMice, NudeRNA StabilityRNA, MessengerCell MovementNeoplasm MetastasisGene Expression Regulation, NeoplasticMice, Inbred BALB CSmad3 ProteinFemaleMaleSmad2 ProteinDEAD-box RNA Helicases

Stichwörter der Autor:innen

EIF4A3Epithelial-mesenchymal transitionGastric cancerPositive feedback loopTGF-β/SMAD

Substanzen

Eukaryotic Initiation Factor-4AEIF4A3 protein, humanTransforming Growth Factor betaRNA, MessengerSmad3 ProteinSmad ProteinsSmad2 ProteinDEAD-box RNA Helicases

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Soochow University, Gusu District, No. 1055, Sanxiang Road, Suzhou, 215008, Jiangsu, China.
  • Suzhou Hospital, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Suzhou, 215100, Jiangsu, China.
  • Suzhou Hospital of Traditional Chinese Medicine, Suzhou, 215100, Jiangsu, China.
  • Department of Obstetrics and Gynecology, Binhai County People's Hospital, Binhai, Yancheng, 224000, Jiangsu, China.
  • Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215008, Jiangsu, China.
  • Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Soochow University, Gusu District, No. 1055, Sanxiang Road, Suzhou, 215008, Jiangsu, China. wuyongyou72@163.com.

Zitieren

APA

Liu, Y., Zhang, Y., Dou, W., Peng, W., Cheng, M., Zhou, Y., Shao, Q., & Wu, Y. (2026). Post-transcriptional activation of TGF-β signaling via SMAD mRNA stabilization by EIF4A3 promotes EMT and metastasis in gastric cancer. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10171-6

Vancouver

Liu Y, Zhang Y, Dou W, Peng W, Cheng M, Zhou Y, et al. Post-transcriptional activation of TGF-β signaling via SMAD mRNA stabilization by EIF4A3 promotes EMT and metastasis in gastric cancer. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-026-10171-6

BibTeX
@article{Liu2026,
  author = {Liu, Yujing and Zhang, Yanhua and Dou, Wenhuan and Peng, Wei and Cheng, Ming and Zhou, Yan and Shao, Qiankun and Wu, Yongyou},
  title = {Post-transcriptional activation of TGF-β signaling via SMAD mRNA stabilization by EIF4A3 promotes EMT and metastasis in gastric cancer},
  journal = {Cell Biology and Toxicology},
  year = {2026},
  doi = {10.1007/s10565-026-10171-6}
}
Kostenlos starten →